Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of 10x Genomics Inc (NASDAQ: TXG) closed at $22.67 in the last session, up 1.66% from day before closing price of $22.30. In other words, the price has increased by $1.66 from its previous closing price. On the day, 1.35 million shares were traded. TXG stock price reached its highest trading level at $23.065 during the session, while it also had its lowest trading level at $22.22.
Ratios:
We take a closer look at TXG’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.42 and its Current Ratio is at 5.22. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on September 03, 2024, initiated with a Outperform rating and assigned the stock a target price of $35.
On July 22, 2024, Jefferies Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $24.
JP Morgan Downgraded its Overweight to Neutral on July 18, 2024, whereas the target price for the stock was revised from $40 to $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 22 ’24 when Saxonov Serge sold 6,749 shares for $22.53 per share. The transaction valued at 152,053 led to the insider holds 882,467 shares of the business.
Hindson Benjamin J. sold 4,351 shares of TXG for $98,027 on Aug 22 ’24. The insider now owns 345,704 shares after completing the transaction at $22.53 per share. On Aug 22 ’24, another insider, McAnear Justin J., who serves as the Former Chief Financial Officer of the company, sold 2,961 shares for $22.53 each. As a result, the insider received 66,710 and left with 143,242 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TXG now has a Market Capitalization of 2731531008 and an Enterprise Value of 2440929536. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.32 while its Price-to-Book (P/B) ratio in mrq is 3.77. Its current Enterprise Value per Revenue stands at 3.864 whereas that against EBITDA is -16.686.
Stock Price History:
Over the past 52 weeks, TXG has reached a high of $57.90, while it has fallen to a 52-week low of $15.28. The 50-Day Moving Average of the stock is 7.05%, while the 200-Day Moving Average is calculated to be -28.82%.
Shares Statistics:
According to the various share statistics, TXG traded on average about 1.84M shares per day over the past 3-months and 1423370 shares per day over the past 10 days. A total of 105.04M shares are outstanding, with a floating share count of 99.61M. Insiders hold about 17.33% of the company’s shares, while institutions hold 81.23% stake in the company. Shares short for TXG as of 1726185600 were 7806668 with a Short Ratio of 4.24, compared to 1723680000 on 10417026. Therefore, it implies a Short% of Shares Outstanding of 7806668 and a Short% of Float of 8.5.
